Go to deals
Private Equity | Healthcare

Naxicap Partners becomes the majority shareholder of Lagarrigue Group

Naxicap Partners has acquired a majority stake in Lagarrigue Group.

As one of the top private equity firms in France, Naxicap Partners – an affiliate of Natixis Investment Managers – has US$4.8 billion in assets under management. As a committed, responsible investor, Naxicap Partners builds solid, constructive partnerships with entrepreneurs so that their projects can succeed. The firm has 39 investment professionals spread across five offices in Paris, Lyon, Toulouse and Nantes in France, and Frankfurt in Germany.

Lagarrigue Group is a global specialist in external orthopedic devices (prostheses/orthoses) and in the design and manufacture of custom-made large orthopedic devices (LAD) for the treatment of disabilities. Lagarrigue is an international player, thanks to a very active external growth strategy that has led to nearly 25 acquisitions since 2016.

Ardian is one of the world’s leading private equity firms with US$110 billion under management and/or advisory in Europe, America and Asia. The firm, majority-owned by its employees, places entrepreneurship at the heart of its approach and offers its international investors top-tier performance.

Oaklins’ team in France acted as advisor to Naxicap Partners in this transaction.

Parties

Talk to the deal team

Hadrien Mollard

Managing Partner
Paris, France
Oaklins France

Raphaël Petit

Managing Partner
Toulouse, France
Oaklins France

Related deals

Valmiermuižas Alus has been acquired by Cēsu Alus
Private Equity | Food & Beverage

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Capsol has been acquired by Angus Capital
Private Equity | Construction & Engineering Services

Capsol has been acquired by Angus Capital

Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.

Learn more